Allscripts (MDRX) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends up on Iran war peace deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Allscripts announces third quarter 2018 results
November 1, 2018 4:01 PM EDTReported third quarter growth of 16% in GAAP revenue to $522 million, 19% in non-GAAP revenue to $536 millionThird quarter GAAP loss per share of $0.20, growth of 13% in non-GAAP EPS to $0.18Year-to-date growth of 21% in GAAP revenue to $1,562 million, 23% in non-GAAP revenue to $1,590 millionYear-to-date GAAP loss per share of $0.06, growth of 18% in non-GAAP EPS to $0.52
CHICAGO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and nine months ended September 30, 2018.
Third... More
